Companies that own Abivax S.A.
Amundi Asset Management SA (Investment Management)
117,461
1.19%
0
0%
01/31/2018
CPR Asset Management SA
43,827
0.44%
0
0%
01/31/2018
Lupus alpha Asset Management AG
37,000
0.37%
12,500
0.02%
12/31/2017
Aviva Investors Global Services Ltd.
21,322
0.22%
-7,820
0%
06/30/2018
Gestys SA
20,000
0.2%
0
2.35%
03/23/2018
Mirabaud Asset Management (France) SASU
13,890
0.14%
13,890
0.08%
06/30/2017
Deka Investment GmbH
7,923
0.08%
-76
0%
03/29/2018
Allianz Global Investors GmbH (France)
300
0%
300
0%
12/31/2015
Perinvest (UK) Ltd.
0
0%
-11,379
0%
06/30/2017
| Address |
5, rue de la Baume
Paris Ile-de-France 75008
France
|
|
Employees
|
- |
| Website |
http://www.abivax.com |
| Updated |
07/08/2019 |
| Abivax SA engages in the sale, research, distribution, and development of biopharmaceutical products. It offers commercial and development products of anti-viral compounds and human vaccines. The commercialized products include vaccines for typhoid fever, meningococcus, and leptospirosis. |
